Posted on July 2nd, 2015
The analysts forecast the global medical waste management market to grow at a CAGR of 5.35% over the period 2014-2019.
This report covers the present scenario and the growth prospects of the global medical waste management market for the period 2015-2019. The market can be divided into two segments based on medical waste generation sources: large quantity generators and small quantity generators. To calculate the market size, the report considers the revenue generated from the two waste generation sources.
Reductions in federal reimbursements have helped healthcare facilities to optimize the sustainability of their operations and improve cost-cutting strategies. Hospitals are now assessing their departments and developing effective plans for the efficient utilization of water and energy and for the organized management of wastes. For instance, Spectrum Health launched a medical device reprocessing platform and implemented a reusable sharps container program in 2008, which helped it save about $1 million in waste management costs. The conversion of biogas (produced from waste) to electricity via the waste treatment process has not only helped in the efficient utilization of waste but it has also made healthcare facilities energy independent.
According to the report, medical consumables – catheters, syringes, saline needles, and reagents – are used in large quantities as ancillary devices in surgeries and laboratory research for sample analyses. Most of medical equipment suppliers, such as Thermo Fisher Scientific, Illumina, Roche Diagnostics, and Alere, invest extensively in the development of consumables, as these products generate higher return on investment than capital equipment. In addition, the National Institutes of Health provides quarterly reimbursements on the R&D of consumables. Medical waste handling companies make higher gross margins from the management of consumables, as they are dumped in bulk quantities. This has also shifted the sales mix – that is, from instruments to consumables – for medical equipment suppliers.
Posted on June 24th, 2015
Brussels, 19 June 2015
MedTech Europe, the alliance of Eucomed and EDMA, welcomes the fact that the Council has opted to move forward with its proposal. At the same time, MedTech Europe notes that Council also recognises a number of areas that still raise concern and thus warrant further work.
It is apparent that Council found it important to make progress on discussions to achieve a balanced regulation for medical devices and in vitro diagnostics. But at the same time a significant number of Member States voiced concern over the unnecessary complexity of the scrutiny mechanism, the approach on reprocessing of single-use devices, the performance evaluation of in vitro diagnostic medical devices and the overall unnecessary additional administrative burden that would still need to be addressed. Industry shares these concerns.
Regarding medical devices, MedTech Europe believes that at least two issues merit particular attention and must be addressed if the EU is serious about providing equal levels of patient safety and treatment across Europe:
- The ‘scrutiny’ mechanism: The newly added “scrutiny” mechanism to bring products to the European market creates heavy procedures that will lead to unnecessary delay in the availability of devices to patients, as well as legal uncertainty in the innovation process. The proposed Regulation has other robust safety controls that strengthen the patient safety net, i.e. by enhancing the quality and expertise of notified bodies. These added controls render the additional ‘scrutiny’ procedure redundant in terms of patient safety and only serve to adversely impact the innovation and growth of the medical device industry. Moreover, the proposed ‘scrutiny’ procedure comes too late in the process and is based on a random selection of products.
- Reprocessing of Single Use devices: Patient safety is a crucial concern when it comes to reusing single use devices. The Regulation should therefore strive to ensure equal levels of safety for all products, regardless of who, in fact, is the reprocessing entity (original manufacturer, commercial reprocessor or hospital reprocessor). Council’s proposal, however, introduces three levels of patient safety depending on the entity who reprocesses. In addition, a non-harmonised approach allowing Member States to decide on national rules means that patients across the EU will not be equally treated. None of this is conducive to improved overall patient safety.
Other key areas that need additional attention include provisions on clinical evidence, hazardous substances and unnecessary bureaucratic burden.
Concerning in vitro diagnostics (IVD), the five-year transition period is in line with the initial proposal from the European Commission and is viewed positively while being in line with experience by other jurisdictions making similar changes to IVD legislation.
- Clinical Evidence: This has always been the aspect of the new IVD regulation that will be having the most impact for the IVD industry. Member States are considering extensive changes to the section of the proposed Regulation on clinical evidence. Overall, the proposal of the council greatly increases the burden of the new clinical evidence requirement for IVDs with unclear benefits for patients, while at the same time breaking the alignment with the international consensus which would have mitigated the impact of the clinical evidence requirements.
- On Companion Diagnostics: the proposed definition is too broad to be functional – too many assays fall under the new definition, creating an almost insurmountable barrier for some of the simpler assays such as cholesterol tests which will fall under the new definition.
Serge Bernasconi, MedTech Europe CEO says, “It is critically important that in the future discussions between Council, Parliament and Commission shortcomings on the key issues such as scrutiny and reprocessing for Medical devices and clinical requirements and Companion diagnostic definition for In Vitro Diagnostics be addressed. The current Council texts as it stands still fail to ensure that every proposed measure consistently meets the two overarching objectives of these Regulations, namely to increase patient safety and to foster innovation in medical technology in Europe bolstering a dynamic part of the European economy.”
Posted on June 23rd, 2015
The health and economic benefits of global climate change policies outweigh the impacts of taking no action, the Obama administration said Monday in a new report, which was released as Congress tries to weaken some of those policies this week.
The new report by the Environmental Protection Agency makes the first attempt to quantify the benefits of global action on climate change by examining 20 key sectors from water to electricity to infrastructure, EPA Administrator Gina McCarthy told reporters Monday.
“The report finds that we can save tens of thousands of American lives, and hundreds of billions of dollars, annually in the United States by the end of this century, and the sooner we act, the better off America and future generations of Americans will be,” McCarthy said.
The EPA is at the center of President Barack Obama’s Climate Action Plan, which he first announced nearly two years ago, which aims to tackle greenhouse gas emissions across different sectors using mainly executive actions and existing authority under federal law.
Posted on June 23rd, 2015
Strong clinical and operational performance at the nation’s high-performing hospitals is associated with their more efficient use of drugs and supplies, according to a new study.
Lower-than-expected use of medical supplies and pharmaceuticals is linked to lower rates of mortality, lower 30-day readmission rates and higher patient-satisfaction scores at hospitals that score well in Truven Health Analytics’ 100 Top Hospitals study, according to an exclusive study conducted for Modern Healthcare by the Ann Arbor, Mich.-based data and research firm.
Truven found that hospitals with less waste—and therefore lower-than-expected supply and pharmacy costs per discharge—outperformed others on multiple quality measures used by Medicare.
The study included 2,560 hospitals from Truven’s flagship 100 Top Hospitals study for which pharmacy and supply data were available from Medicare. Together, the hospitals reported nearly 5.3 million discharges.
Posted on June 11th, 2015
Healthcare Facilities Focus on Recycling & Safer Chemicals
US hospitals are making an effort to use safer chemicals and reduce waste, and they’re seeing results, according to a report released by the Healthier Hospitals Initiative. The study demonstrates the results of initiatives designed to improve both operating efficiency and patient outcomes, such as safer chemicals, waste reduction, and energy efficiency.
The purchasing program seeks to transition facilities to using PVC- and DEHP-free devices, greener cleaning products, and furnishings that do not contain halogenated flame retardants, formaldehyde, perfluorinated compounds, or PVC. According to the report, the program has been responsible for an 11% increase in spending on certified cleaning products, 172 hospitals reporting to have made at least one product-line DEHP and PVC-free, and fourteen facilities meeting the goal of purchasing over 25% healthy furnishings.
Posted on June 5th, 2015
Medical Market Research reports announcements:
The global reprocessed medical devices market is expected to exhibit significant growth over the forecast period due to factors such as the rising significance of medical waste minimization which eradicates environmental concerns.
Novel advancements in techniques of testing, inspecting, cleaning & sterilizing the devices reported safe clinical application are also high impact rendering drivers for the market.
These methods include utilization of chemical sterilants such as ortho-phthalaldehyde and incorporation of ultrasonic washer. Consequentially, benefits includes greater patient safety, increased reusable cycle time and efficacy are expected to increase demand for the reprocessed medical devices market over the forecast period.
View the Grandview Research report here.
Posted on June 4th, 2015
Sustainability Practices Benefit Hospitals’ Bottom Lines
Health care costs in the United States are out of control, but implementing sustainability practices is one way that hospitals can help keep costs fromincreasing further.
Increased energy efficiency means lower energy costs for hospitals and clinics, just as it does for any other consumer. Hospitals that invest in reusable medical supplies wherever possible spend less money on disposables, in addition to eating up fewer resources.
When hospitals and other health care facilities commit to protecting the environment, employee engagement improves. That’s because health care workers often care deeply about the environment, and understand the intricate connections between environmental hazards, like pollution, and poor health. Employees in all industries are happier when they’re able to work for organizations that reflect their own personal values, and health care workers are no exception to that rule.
Patients care about sustainability too, and as more patients are empowered to make choices about their health care, institutions that support sustainability practices are more likely to attract the business of eco-conscious patients.
Sustainability issues are more important than ever before, especially for the health care industry, which uses vast amounts of resources in the name of sanitation and good patient outcomes. But patients do better in facilities that make sustainability practices a priority — and so do employees. Since nurses are responsible for much of patient care, they’re uniquely positioned to promote sustainability concerns in the health care industry, and help the organizations they work for make the changes demanded by dwindling resources…
Posted on May 20th, 2015
…Whether you’re just getting started or well on your way, the right tools can help further transform your supply chain process. This checklist provides an overview of some key environmental purchasing strategies suggested by Practice Greenhealth for award-winning hospitals.
Choosing a more environmentally preferred product or service is just one small decision—but when these small decisions happen across your hospital, it makes a measurable difference in the health and safety of your staff, patients and community. From reducing waste to recycling and saving energy, facilities can easily quantify their overall success by asking vendors for spend or tonnage reports. Many hospitals are also finding that, by including environmental attributes as part of their evaluations of products and services, they are seeing significant savings in a product’s total cost over its lifetime…
Posted on May 14th, 2015
Dartmouth-Hitchcock Medical Center is this year’s Greening the OR Award winner.
The OR is a large contributor to a health care facility’s environmental footprint, but health systems nationwide are transforming their surgical suites through environmental innovation. This year, Practice Greenhealth is pleased to recognize Dartmouth-Hitchcock Medical Center (D-H) for its outstanding efforts to reduce the environmental impact of the surgical environment….
…D-H also has success with its single-use device (SUD) reprocessing program. In 2014, D-H saw significant growth in collection compliance of multiple noninvasive devices (pulse oximeters, ECG leads, DVT sleeves, blood pressure cuffs) along with an improvement in buy-back compliance of external-fixation devices. The team diverted more than nine tons of SUDs from the OR, Cath/EP labs and patient care areas for a savings of $8,758 in avoided waste disposal costs and $211,726 in the purchase of reprocessed devices…
Posted on May 14th, 2015
From p. 23 of the Report:
One of the goals of the Smarter Purchasing Challenge is to increase the purchases of reprocessed SUDs by at least 50 percent over baseline. While the collection of FDA-approved SUDs for reprocessing reduces waste tonnage and disposal costs, it is equally important for hospitals to purchase back the reprocessed devices to maintain the demand, closing the loop.
… Since 2010, 379 hospitals saved more than $174 million by purchasing reprocessed single-use devices. Hospitals generally buy back the reprocessed SUDs at 1/2 the original purchase price. Three hundred seventy-nine different hospitals reported data on SUD purchases since 2010. Of the 119 hospitals reporting data in 2014 that have a continuous purchasing series (2010-2014, 2011-2014, 2012-2014 or 2013-2014):
• Fifty (42 percent) increased purchases compared to the first year in the reporting series.
• Thirty-one (26 percent) reported increasing purchasing of reprocessed devices by more than 50 percent in 2014 relative to the first year in the reporting series.
HHI has been able to quantify $174.4 million in reprocessed SUD expenditure since 2010. While it is fantastic that hospitals are spending such a large sum of money on reprocessed devices, there are numerous roadblocks to implementing an SUD purchasing program, ranging from physician buy-in to leadership support. Practice Greenhealth will continue to work with hospitals, tackling barriers around contracting limits, clinical engagement, and ongoing training and auditing needs.
To download a copy of the full report, visit www.HealthierHospitals.org/Milestone